PILL CONTAINING 1-(3-(2-(1-BENZOTHIOPHEN-5-YL)ETHOXY)PROPYL)AZETIDIN-3-OL OR ITS SALTS Russian patent published in 2020 - IPC A61K9/20 A61K9/28 A61K31/397 A61K47/38 A61P25/00 

Abstract RU 2733404 C2

FIELD: pharmaceutical industry.

SUBSTANCE: invention relates to a pill for treating the central nervous system or peripheral nerves, including 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or its pharmaceutically acceptable salt and ethyl cellulose in amount of 1–30 % of the weight of the pill.

EFFECT: invention provides high impact strength compared to a pill which does not contain ethyl cellulose.

9 cl, 5 tbl, 22 ex

Similar patents RU2733404C2

Title Year Author Number
SOLID PHARMACEUTICAL COMPOSITION CONTAINING 1-(3-(2-(1-BENZOTHIOPHENE-5-YL)ETOXY)PROPYL)AZETIDINE-3-OL OR ITS SALT 2013
  • Inaba Khiroyuki
  • Nagata Mitsukhiro
RU2625767C2
PILL CONTAINING METHANESULFONATE HYDRATE OF 1-CYCLOPROPYL-8-(DIFLUOROMETHOXY)-7-[(1R)-1-METHYL-2,3-DIHYDRO-1H-ISOINDOLE-5-YL]-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID 2012
  • Kakuda Sakhoe
  • Miyadzaki Tsutomu
  • Okada Kotaro
RU2633477C2
TABLET CONTAINING 5-HYDROXY-1H-IMIDAZOLE-4-CARBOXAMIDE 2014
  • Yamasaki Yasuomi
RU2654703C2
PHARMACEUTICAL COMBINED DRUG 2014
  • Myung, Jayhyuk
  • Nam, Kyung Wan
  • Lee, Cheol Woo
  • Kim, Ju Won
RU2639818C2
DRUG FOR PREVENTION OR TREATMENT OF BRAIN ATROPHY 2018
  • Kobayashi Hiroshi
  • Matsumoto Yoshihiko
RU2759727C2
ORAL COMPOSITION CONTAINING 3-{5-[4-(CYCLOPENTLOXY)-2-HYDROXYBENZOYL]-2-[(3-HYDROXY-1,2-BENZISOXAZOL-6-YL)METHOXY]PHENYL}PROPIONIC ACID OR ITS SALT 2007
  • Kakuda Sakhoe
  • Jakhata Tatsukhito
  • Kaneko Masasi
RU2436576C2
TABLET, WHICH IS DECOMPOSED IN MOUTH 2008
  • Matsuoka Makoto
  • Nisii Khirojuki
  • Kavamura Maki
RU2478375C2
DRUG FOR PREVENTION OR TREATMENT OF TAUPATHY 2018
  • Kobayashi Hiroshi
  • Matsumoto Yoshihiko
RU2739199C1
SOLID DOSAGE FORMS OF (S)-ETHYL 2-AMINO-3-(4-(2-AMINO-6-((R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHOXY)PYRIMIDIN-4-YL)PHENYL)PROPANOATE 2012
  • Chen Tszinlin
  • Diver Mettyu S.
  • Kholl Richard Dzh.
  • Nuguru Kalian
RU2661402C2
ORAL PHARMACEUTICAL COMPOSITION 2013
  • Okhnisi Josito
  • Ogata Tetsuo
RU2639473C2

RU 2 733 404 C2

Authors

Kano Atsusi

Inaba Khiroyuki

Oura Taj

Dates

2020-10-01Published

2016-12-22Filed